sale transaction MA deal changing hands money money changing hands
Pharma

Ultragenyx cashes in a pair of FDA review vouchers for $413M

Hot off a pair of key FDA approvals this summer, Ultragenyx has wasted little time cashing in on a pair of priority review vouchers it earned.
Fraiser Kansteiner Oct 14, 2026 4:19pm
United Therapeutics HQ

United lines up $380M settlement from Liquidia in patent feud

Oct 14, 2026 10:33am
Illustration connected puzzle pieces with the acronym MA

Galderma targets medical skincare growth with $1.5B Zo buyout

Oct 14, 2026 10:31am
Hiking gear with a forest in the background

AbbVie slots in ‘Time For Treks’ with CLL community walk

Oct 14, 2026 10:05am
Magnifying glass with pills on blue

Regulatory tracker: FDA accepts Ebvallo resubmission, PFP's 3rd

Oct 14, 2026 9:45am
Martin Shkreli

FTC alleges Martin Shkreli violated pharma ban with stock trades

Oct 14, 2026 8:40am
More News

Soon-Shiong backs rounds for Prolific Machines, Multiply Labs

Oct 14, 2026 7:52am

Sanofi dodges fine over alleged disparagement of CSL flu vaccine

Oct 14, 2026 7:18am
Fierce Biotech

GSK to lay off 1,200 roles in Belgium under cost-saving program

Oct 14, 2026 6:37am

Syndax ends IPF development after phase 2 disappointment

Oct 13, 2026 11:25am